£490.00

It has never been this cheap. We have no record of a lower price.

£490 today · cheaper than every other day in the last 3 months

Squamous Cell Carcinoma Head and Neck Treatment Outlook

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 32 days · 32 data points (no recent data)

Historical
Generating forecast…
£490.00 £465.50 £475.30 £485.10 £494.90 £504.70 £514.50 03 August 2026 10 August 2026 18 August 2026 26 August 2026 03 September 2026
View at Amazon ↗

Price data last checked 59 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 32 days • 1 price levels

Days at Price
32 days 0 8 16 24 32 £490 Days at Price

Price Analysis

Most common price: £490 (32 days, 100.0%)

Price range: £490 - £490

Price levels: 1 different prices over 32 days

Description

This specialized study provides a detailed outlook for squamous cell carcinoma of the head and neck treatments from 2023 to 2028. It focuses on the United States, delivering latent demand estimates across 10,833 specific zip codes. By providing potential industry earnings (P.I.E.) in millions of U.S. dollars, this report serves as a data-driven resource for understanding market opportunities. The data includes comparative benchmarks by calculating the percent share each zip code holds within its state and the United States as a whole. These metrics allow users to quickly gauge specific geographic areas against others. This statistical approach provides highly useful information for distribution planning and market analysis within the healthcare sector.

Key Features

Provides latent demand outlook for squamous cell carcinoma of the head and neck treatments from 2023 to 2028.

Includes potential industry earnings (P.I.E.) estimates in millions of U.S. dollars for 10,833 US zip codes.

Delivers comparative benchmarks by reporting the percent share of each zip code relative to its state and the US.

Offers a statistical approach designed to assist with distribution and market analysis across the United States.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
09 January 2023
Listed Since
27 January 2023

Similar Products You Might Like

Head and Neck Cancer Outlook 2023-2028 - US Zip Code Study
98% match

Head and Neck Cancer Outlook 2023-2028 - US Zip Code Study

£490.00 26 Aug 2026
Basal Cell Carcinoma Surgery Outlook 2023-2028 US Report
96% match

Basal Cell Carcinoma Surgery Outlook 2023-2028 US Report

£490.00 21 Aug 2026
Basal Cell Carcinoma Treatment Outlook 2023-2028 Report
96% match

Basal Cell Carcinoma Treatment Outlook 2023-2028 Report

£490.00 20 Aug 2026
Head and Neck Oncology Nutrition Outlook 2023-2028 Study
96% match

Head and Neck Oncology Nutrition Outlook 2023-2028 Study

£490.00 03 Sep 2026
The 2023-2028 Outlook for Basal Cell Carcinoma Surgeries in China
96% match

The 2023-2028 Outlook for Basal Cell Carcinoma Surgeries in China

£495.00 26 Aug 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics for US Zip Codes
96% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics for US Zip Codes

£490.00 02 Oct 2026
US Cancer Screening Outlook 2023-2028 - Zip Code Study
96% match

US Cancer Screening Outlook 2023-2028 - Zip Code Study

£490.00 24 Aug 2026
Cervical Cancer Treatment Outlook 2023-2028 US Zip Codes
96% match

Cervical Cancer Treatment Outlook 2023-2028 US Zip Codes

£490.00 26 Aug 2026
The 2025-2030 World Outlook for Basal Cell Carcinoma Surgeries
96% match

The 2025-2030 World Outlook for Basal Cell Carcinoma Surgeries

Price unavailable
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in China
96% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in China

£495.00 01 Oct 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in Japan
96% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in Japan

£495.00 26 Sep 2026
The 2023-2028 Outlook for Cancer Testing-Screening for US Zip Codes
96% match

The 2023-2028 Outlook for Cancer Testing-Screening for US Zip Codes

£490.00 01 Oct 2026
The 2023-2028 Outlook for Basal Cell Carcinoma Treatments in India
96% match

The 2023-2028 Outlook for Basal Cell Carcinoma Treatments in India

£515.00 12 Sep 2026
Non-Small Cell Lung Cancer Outlook 2023-2028 US Zip Codes
96% match

Non-Small Cell Lung Cancer Outlook 2023-2028 US Zip Codes

£490.00 26 Aug 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in China
96% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancers in China

£495.00 02 Oct 2026
The 2023-2028 Outlook for Cervical Cancer Treatments in China
96% match

The 2023-2028 Outlook for Cervical Cancer Treatments in China

£495.00 23 Aug 2026
The 2023-2028 Outlook for Cancer Supportive Care in the United States
96% match

The 2023-2028 Outlook for Cancer Supportive Care in the United States

£520.00 22 Aug 2026
The 2023-2028 Outlook for Cancer Screenings in the United States
96% match

The 2023-2028 Outlook for Cancer Screenings in the United States

£520.00 20 Aug 2026
The 2025-2030 World Outlook for Cancer Specialty Hospitals
96% match

The 2025-2030 World Outlook for Cancer Specialty Hospitals

Price unavailable
The 2023-2028 Outlook for Cervical Cancer Treatments in the United States
96% match

The 2023-2028 Outlook for Cervical Cancer Treatments in the United States

£520.00 25 Aug 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in Japan
96% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancers in Japan

£495.00 26 Sep 2026
NSCLC Therapeutics Outlook in Asia (2013-2018) Study
96% match

NSCLC Therapeutics Outlook in Asia (2013-2018) Study

£325.00 27 Aug 2026
The 2025-2030 World Outlook for Cancer Screenings
95% match

The 2025-2030 World Outlook for Cancer Screenings

Price unavailable
US Cancer Diagnostics Lab Test Outlook 2023-2028 Study
95% match

US Cancer Diagnostics Lab Test Outlook 2023-2028 Study

£490.00 24 Aug 2026